MEI Pharma CEO Daniel Gold's 2022 pay slips 14% to $2.5M
MEI Pharma reports 2022 executive compensation
By ExecPay News
Published: October 27, 2022
MEI Pharma reported fiscal year 2022 executive compensation information on October 27, 2022.
In 2022, four MEI Pharma executives received on average a compensation package of $1.6M, a 2% decrease compared to previous year.
Average pay of disclosed executives at MEI Pharma
Daniel P. Gold, Chief Executive Officer, received $2.5M in total, which decreased by 14% compared to 2021. 61% of Gold's compensation, or $1.5M, was in option awards. Gold also received $275K in non-equity incentive plan and $717K in salary.
David M. Urso, Chief Operating Officer, received a compensation package of $1.7M, which decreased by 18% compared to previous year. 62% of the compensation package, or $1.1M, was in option awards.
Richard G. Ghalie, Chief Medical Officer, earned $1.2M in 2022, a 1% increase compared to previous year.
Brian G. Drazba, Chief Financial Officer, received $880K in 2022, which decreases by 20% compared to 2021.
MEI Pharma's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 27, 2022.